Free tool
FAERS Monitor: Flovent Hfa
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021433 or its brand name (Flovent Hfa, Fluticasone Propionate). Reports on generic versions are filed under their own applications.
Reports
31,126
Serious
18,055
58% of reports
Hospitalization
8,132
Death reported
1,768
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea2,509
- drug ineffective2,459
- headache2,365
- fatigue2,182
- off label use1,946
- pain1,928
- nausea1,889
- cough1,819
- asthma1,697
- diarrhoea1,677
- product dose omission issue1,531
- pneumonia1,488
- dizziness1,438
- malaise1,278
- vomiting1,244
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 383 |
| 2005 | 329 |
| 2006 | 341 |
| 2007 | 414 |
| 2008 | 430 |
| 2009 | 383 |
| 2010 | 584 |
| 2011 | 917 |
| 2012 | 1,014 |
| 2013 | 372 |
| 2014 | 485 |
| 2015 | 1,120 |
| 2016 | 1,530 |
| 2017 | 1,239 |
| 2018 | 1,698 |
| 2019 | 1,719 |
| 2020 | 2,076 |
| 2021 | 1,883 |
| 2022 | 2,240 |
| 2023 | 2,740 |
| 2024 | 3,360 |
| 2025 | 3,368 |
| 2026 | 2,500 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,023,033 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| asthmaSignal | 1,697 | 10.3 | 9.8 | 14,079 |
| coughSignal | 1,819 | 4.4 | 4.2 | 4,818 |
| product dose omission issueSignal | 1,531 | 3.5 | 3.4 | 2,800 |
| pneumoniaSignal | 1,488 | 3.1 | 3.0 | 2,159 |
| dyspnoeaSignal | 2,509 | 3.0 | 2.9 | 3,429 |
| headacheSignal | 2,365 | 2.6 | 2.5 | 2,296 |
| painSignal | 1,928 | 2.1 | 2.0 | 1,177 |
| malaise | 1,278 | 2.0 | 1.9 | 622 |
| dizziness | 1,438 | 2.0 | 1.9 | 680 |
| fatigue | 2,182 | 1.9 | 1.8 | 956 |
| vomiting | 1,244 | 1.8 | 1.7 | 442 |
| diarrhoea | 1,677 | 1.8 | 1.7 | 563 |
| nausea | 1,889 | 1.6 | 1.5 | 457 |
| off label use | 1,946 | 1.5 | 1.4 | 340 |
| drug ineffective | 2,459 | 1.3 | 1.2 | 141 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.